{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:11Z","timestamp":1772165711899,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University","award":["YJSCX202207"],"award-info":[{"award-number":["YJSCX202207"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Special Funding Project of Chongqing Yongchuan District Research Platform","award":["YJYJ202135"],"award-info":[{"award-number":["YJYJ202135"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]},{"name":"the College-level Topics of Yongchuan Hospital of Chongqing Medical University","award":["YJYJ201601"],"award-info":[{"award-number":["YJYJ201601"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04088-6","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:04:51Z","timestamp":1740373491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Chinese patient with cardiogenic stroke and warfarin resistance: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoyan","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"4088_CR1","doi-asserted-by":"publisher","unstructured":"Takeuchi M, Kobayashi T, Brand\u00e3o LR, Ito S. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis. Syst Reviews. 2016;5(1:105). https:\/\/doi.org\/10.1186\/s13643-016-0280-y.","DOI":"10.1186\/s13643-016-0280-y"},{"key":"4088_CR2","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fphar.2020.01014","volume":"11","author":"Y Ren","year":"2020","unstructured":"Ren Y, Yang C, Chen H, Dai D, Wang Y, Zhu H, et al. Pharmacogenetic-guided algorithm to Improve Daily Dose of Warfarin in elder Han-Chinese Population. Front Pharmacol. 2020;11:1014. https:\/\/doi.org\/10.3389\/fphar.2020.01014.","journal-title":"Front Pharmacol"},{"key":"4088_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43 7","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43 7:561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395.","journal-title":"Eur Heart J"},{"key":"4088_CR4","doi-asserted-by":"publisher","unstructured":"Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European heart journal. 2020;41 4:543\u2013603; https:\/\/doi.org\/10.1093\/eurheartj\/ehz405","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"4088_CR5","doi-asserted-by":"publisher","first-page":"Cd011373","DOI":"10.1002\/14651858.CD011373.pub2","volume":"11 11","author":"M Kimachi","year":"2017","unstructured":"Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev. 2017;11 11:Cd011373. https:\/\/doi.org\/10.1002\/14651858.CD011373.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"4088_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1182\/blood-2015-02-627042","volume":"126 4","author":"NA Limdi","year":"2015","unstructured":"Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, et al. Race influences warfarin dose changes associated with genetic factors. Blood. 2015;126 4:539\u201345. https:\/\/doi.org\/10.1182\/blood-2015-02-627042.","journal-title":"Blood"},{"key":"4088_CR7","doi-asserted-by":"publisher","unstructured":"Jin DY, Chen X, Liu Y, Williams CM, Pedersen LC, Stafford DW, et al. A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nat Commun. 2023;14(1:828). https:\/\/doi.org\/10.1038\/s41467-023-36446-8.","DOI":"10.1038\/s41467-023-36446-8"},{"key":"4088_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1161\/circulationaha.121.054990","volume":"146 23","author":"SD Pokorney","year":"2022","unstructured":"Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, et al. Apixaban for patients with Atrial Fibrillation on hemodialysis: a Multicenter Randomized Controlled Trial. Circulation. 2022;146 23:1735\u201345. https:\/\/doi.org\/10.1161\/circulationaha.121.054990.","journal-title":"Circulation"},{"key":"4088_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/1076029618755311","volume":"24 6","author":"LM Groetzinger","year":"2018","unstructured":"Groetzinger LM, Miller TJ, Rivosecchi RM, Smith RE, Gladwin MT, Rivera-Lebron BN. Apixaban or Rivaroxaban Versus Warfarin for treatment of Submassive Pulmonary Embolism after Catheter-Directed Thrombolysis. Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis. 2018;24 6:908\u201313. https:\/\/doi.org\/10.1177\/1076029618755311.","journal-title":"Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/hmg\/ddi180","volume":"14 13","author":"HY Yuan","year":"2005","unstructured":"Yuan HY, Chen JJ, Lee MT, Wung JC, Chen YF, Charng MJ, et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet. 2005;14 13:1745\u201351. https:\/\/doi.org\/10.1093\/hmg\/ddi180.","journal-title":"Hum Mol Genet"},{"key":"4088_CR11","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1182\/blood-2008-01-135863","volume":"111 7","author":"E Aklillu","year":"2008","unstructured":"Aklillu E, Leong C, Loebstein R, Halkin H, Gak E. VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals. Blood. 2008;111 7:3903\u20134. https:\/\/doi.org\/10.1182\/blood-2008-01-135863.","journal-title":"Blood"},{"key":"4088_CR12","doi-asserted-by":"publisher","unstructured":"Sabol BJ, Basa RR, Wilkins CE. Malabsorption-associated warfarin resistance. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists. 2009;66 17:1548\u201353; https:\/\/doi.org\/10.2146\/ajhp080477","DOI":"10.2146\/ajhp080477"},{"key":"4088_CR13","first-page":"215","volume":"19 4","author":"P Sinxadi","year":"2008","unstructured":"Sinxadi P, Blockman M. Warfarin resistance. Cardiovasc J Afr. 2008;19 4:215\u20137.","journal-title":"Cardiovasc J Afr"},{"key":"4088_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/pgpm.S404474","volume":"16","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhai Z, Li P. One Rare Warfarin Resistance Case and possible mechanism exploration. Pharmacogenomics Personalized Med. 2023;16:609\u201315. https:\/\/doi.org\/10.2147\/pgpm.S404474.","journal-title":"Pharmacogenomics Personalized Med"},{"key":"4088_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40291-021-00549-z","volume":"25 6","author":"TDC Hirata","year":"2021","unstructured":"Hirata TDC, Dagli-Hernandez C, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, et al. Cardiovascular Pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Mol Diagn Ther. 2021;25 6:735\u201355. https:\/\/doi.org\/10.1007\/s40291-021-00549-z.","journal-title":"Mol Diagn Ther"},{"key":"4088_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363 8","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363 8:711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1003466.","journal-title":"N Engl J Med"},{"key":"4088_CR17","doi-asserted-by":"publisher","first-page":"866058","DOI":"10.3389\/fphar.2022.866058","volume":"13","author":"IG Asiimwe","year":"2022","unstructured":"Asiimwe IG, Pirmohamed M. Ethnic Diversity and Warfarin Pharmacogenomics. Front Pharmacol. 2022;13:866058. https:\/\/doi.org\/10.3389\/fphar.2022.866058.","journal-title":"Front Pharmacol"},{"key":"4088_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/bloodadvances.2021006876","volume":"7 10","author":"S Li","year":"2023","unstructured":"Li S, Sun J, Liu S, Zhou F, Gross ML, Li W. Missense VKOR mutants exhibit severe warfarin resistance but lack VKCFD via shifting to an aberrantly reduced state. Blood Adv. 2023;7 10:2271\u201382. https:\/\/doi.org\/10.1182\/bloodadvances.2021006876.","journal-title":"Blood Adv"},{"key":"4088_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/clpt.2011.185","volume":"90 4","author":"JA Johnson","year":"2011","unstructured":"Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, et al. Clinical pharmacogenetics implementation Consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011;90 4:625\u20139. https:\/\/doi.org\/10.1038\/clpt.2011.185.","journal-title":"Clin Pharmacol Ther"},{"key":"4088_CR20","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/cpt.2549","volume":"111 4","author":"KJ Lindley","year":"2022","unstructured":"Lindley KJ, Limdi NA, Cavallari LH, Perera MA, Lenzini P, Johnson JA, et al. Warfarin Dosing in patients with CYP2C9*5 variant alleles. Clin Pharmacol Ther. 2022;111 4:950\u20135. https:\/\/doi.org\/10.1002\/cpt.2549.","journal-title":"Clin Pharmacol Ther"},{"key":"4088_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","volume":"102 3","author":"JA Johnson","year":"2017","unstructured":"Johnson JA, Caudle KE, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, et al. Clinical pharmacogenetics implementation Consortium (CPIC) Guideline for Pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther. 2017;102 3:397\u2013404. https:\/\/doi.org\/10.1002\/cpt.668.","journal-title":"Clin Pharmacol Ther"},{"key":"4088_CR22","doi-asserted-by":"publisher","first-page":"8898922","DOI":"10.1155\/2023\/8898922","volume":"2023","author":"Y Altawil","year":"2023","unstructured":"Altawil Y, Youssef LA. Frequencies of VKORC1-1639G\u2009>\u2009A and rs397509427 in patients on Warfarin and healthy Syrian subjects. Cardiovasc Ther. 2023;2023:8898922. https:\/\/doi.org\/10.1155\/2023\/8898922.","journal-title":"Cardiovasc Ther"},{"key":"4088_CR23","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood-2017-09-804666","volume":"131 25","author":"MA Rishavy","year":"2018","unstructured":"Rishavy MA, Hallgren KW, Wilson L, Singh S, Runge KW, Berkner KL. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase. Blood. 2018;131 25:2826\u201335. https:\/\/doi.org\/10.1182\/blood-2017-09-804666.","journal-title":"Blood"},{"key":"4088_CR24","doi-asserted-by":"publisher","unstructured":"Farajzadeh-Dehkordi M, Mafakher L, Samiee-Rad F, Rahmani B. Computational analysis of missense variant CYP4F2*3 (V433M) in association with human CYP4F2 dysfunction: a functional and structural impact. BMC Mol cell Biology. 2023;24(1:17). https:\/\/doi.org\/10.1186\/s12860-023-00479-0.","DOI":"10.1186\/s12860-023-00479-0"},{"key":"4088_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2133\/dmpk.dmpk-10-rg-080","volume":"26 2","author":"O Singh","year":"2011","unstructured":"Singh O, Sandanaraj E, Subramanian K, Lee LH, Chowbay B. Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients. Drug Metab Pharmacokinet. 2011;26 2:130\u20136. https:\/\/doi.org\/10.2133\/dmpk.dmpk-10-rg-080.","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04088-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04088-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04088-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:04Z","timestamp":1740373504000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04088-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04088-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4188009\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Medical Ethics Committee of Yongchuan Hospital Affiliated with Chongqing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish this case report was obtained from the patient and her family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The publication of the case details in this study was approved by our hospital.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of institution approval"}}],"article-number":"77"}}